Response to a Letter to the Editor regarding “The Integrated 31-Gene Expression Profile (i31-GEP) Test for Cutaneous Melanoma Outperforms a Clinicopathologic-Only Nomogram at Identifying Patients who can Forego Sentinel Lymph Node Biopsy”

Main Article Content

Danny Zakria
Icahn School of Medicine at Mount Sinai

Nicholas Brownstone
Temple Univeristy Health

Darrell Rigel
Icahn School of Medicine at Mount Sinai

Keywords

melanoma, MIA, nomogram, sentinel lymph node biopsy, SLNB, survival, node positivity

References

1. Zakria, D., Brownstone, N. & Rigel, D. The Integrated 31-Gene Expression Profile (i31-GEP) Test for Cutaneous Melanoma Outperforms a Clinicopathologic-only Nomogram at Identifying Patients who can Forego Sentinel Lymph Node Biopsy. SKIN The Journal of Cutaneous Medicine 6, 463–473 (2022). https://jofskin.org/index.php/skin/article/view/1795/1476

2. Vickers, A. J., van Calster, B. & Steyerberg, E. W. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res 3, 18 (2019).

3. Hosein, S. et al. Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy? J Surg Oncol (2023) doi:10.1002/jso.27231.

4. Mikiver, R. et al. Population-based validation of the melanoma institute australia (MIA) and the memorial sloan-kettering cancer center (MSKCC) predictive tool for sentinel node status in patients with melanoma. Journal of Clinical Oncology (2023) doi:10.1200/JCO.2023.41.16_suppl.9571.

5. Marchetti, M. A., Dusza, S. W. & Bartlett, E. K. Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma. JAMA Dermatology (2022) doi:10.1001/jamadermatol.2022.0970.

Article Sidebar

PDF
Published
Nov 13, 2023
DOI https://doi.org/10.25251/skin.7.6.8

Article Details

How to Cite
Zakria, D., Brownstone, N., & Rigel, D. (2023). Response to a Letter to the Editor regarding “The Integrated 31-Gene Expression Profile (i31-GEP) Test for Cutaneous Melanoma Outperforms a Clinicopathologic-Only Nomogram at Identifying Patients who can Forego Sentinel Lymph Node Biopsy”. SKIN The Journal of Cutaneous Medicine, 7(6), 1131–1132. https://doi.org/10.25251/skin.7.6.8
Issue
Vol. 7 No. 6 (2023): November 2023 Issue
Section
Editorials
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 4 > >>